General Information of Drug Transporter (DT)
DT ID DTD0480 Transporter Info
Gene Name SLC8B1
Transporter Name Mitochondrial sodium/calcium exchanger protein
Gene ID
80024
UniProt ID
Q6J4K2
Post-Translational Modification of This DT
Overview of SLC8B1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

60

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC8B1 Asparagine 60 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC8B1 Cystine 123 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Incerasing the activity of SLC8B1 [3]

Role of PTM

Protein Activity Modulation

Modified Residue

Serine

Modified Location

258

Related Enzyme

cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8B1 Serine 258 have been reported to increase its transport activity.

  PTM Phenomenon 2

Have the potential to influence SLC8B1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

271

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8B1 Serine 271 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC8B1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

273

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8B1 Serine 273 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

341

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8B1 Threonine 341 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8B1 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

456

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8B1 Threonine 456 has the potential to affect its expression or activity.

Ubiquitination

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [6]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

125

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC8B1 Asparagine 125 has the potential to affect its expression or activity.

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

316

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC8B1 Lysine 316 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8B1 [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

320

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC8B1 Lysine 320 has the potential to affect its expression or activity.

  Phenylalanine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [6] , [8]

Role of PTM

Potential impacts

Modified Residue

Phenylalanine

Modified Location

121

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC8B1 Phenylalanine 121 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8B1 [6] , [8]

Role of PTM

Potential impacts

Modified Residue

Phenylalanine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC8B1 Phenylalanine 260 has the potential to affect its expression or activity.

  Proline

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8B1 [6]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

264

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC8B1 Proline 264 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NCLX_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 PKA Phosphorylation of NCLX Reverses Mitochondrial Calcium Overload and Depolarization, Promoting Survival of PINK1-Deficient Dopaminergic Neurons. Cell Rep. 2015 Oct 13;13(2):376-86.
4 Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J Proteome Res. 2010 Dec 3;9(12):6786-94.
5 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
7 Exploring the human leukocyte phosphoproteome using a microfluidic reversed-phase-TiO2-reversed-phase high-performance liquid chromatography phosphochip coupled to a quadrupole time-of-flight mass spectrometer. Anal Chem. 2010 Feb 1;82(3):824-32.
8 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
9 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.